Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebocontrolled, parallel-group study
However, the market remained relatively small until semaglutide, initially approved for type 2 diabetes under the brand name Ozempic, gained widespread attention for its significant weight loss effects
However, it is assumed that an increased B12 level only alters the gene activity of skin bacteria in some people why this is also remains unclear
Since stopping and starting is so common, my colleagues and I thought it was worth investigating whether or not the GLP-1s work as well each time, said Leung
Read Full Article Here Nicola Traverso et al (2013)